Many Investors Still Treating Gilead: 4 Launches This Year Could Prove Them Wrong
Gilead sits at a crossroads: the HIV backbone remains strong, but a quartet of new launches could reshape the company...
The three pillars of wealth building are essential for financial success. Understand these key concepts to enhance your wealth strategy.
16,558 articlesGilead sits at a crossroads: the HIV backbone remains strong, but a quartet of new launches could reshape the company...
SK hynix's IPO opened with fanfare but quickly cooled, echoing a SpaceX pattern. Investors are weighing whether the p...
When biotech headlines hit, stocks can swing quickly. Here’s a grounded look at why stock skyrocketed today for Q32 B...
General Dynamics posted a strong first quarter, while Lockheed Martin unveiled a major Ultra Maritime purchase, sharp...
Cantor Fitzgerald partners with Securitize to explore blockchain-native IPO shares, signaling a shift toward real-tim...
Rising chatter about a Stripe-PayPal tie-up to build on-chain payments rails has fintech investors watching closely. ...
The EU's MiCA regime moves from plan to enforcement, reshaping costs, governance and market trust for crypto startups...
The XRP Ledger reached 8 million activated accounts, a milestone underscoring growing on-chain adoption as the market...
A director’s stock sale can spark worry, but not every insider move is a warning. This guide shows how to assess trad...
Bitcoin spot ETFs posted a green week after weeks of outflows, while Ethereum ETFs drew stronger inflows, underscorin...
AI-driven demand is reshaping chip markets, but selecting the right names matters. This guide highlights five semicon...
Aflac has a remarkable 43-year streak of raising its dividend, a hallmark many income investors look for. But that st...